Allicin can reduce neuronal death and ameliorate the spatial memory impairment in Alzheimer's disease models

Neurosciences

Volumn 15, Issue 4, 2010, Pages 237-243

  Li, Xian Hui ^a   Li, Chun Yan ^a   Xiang, Zhi Gang ^a   Zhong, Fei ^a   Chen, Zheng Ying ^a   Lu, Jiang Ming ^a  

^a JISHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALLICIN; AMYLOID BETA PROTEIN[1-42]; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATE BUFFERED SALINE; SUPEROXIDE DISMUTASE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; LATENT PERIOD; LEARNING DISORDER; MALE; MEMORY DISORDER; MOUSE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; CELL DEATH; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY DISORDERS; MICE; MICE, INBRED STRAINS; NEURONS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDE FRAGMENTS; SULFINIC ACIDS; TIME FACTORS;

EID: 78649714004     PISSN: 13196138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neuro 2001; 60: 759-767.
2. Lovell MA, Markesbery WR. Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease. Nucleic Acids Res 2007; 35: 7497-7504.
3. Eftekharzadeh B, Maghsoudi N, Khodagholi F. Stabilization of transcription factor Nrf2 by tBHQ prevents oxidative stressinduced amyloid beta formation in NT2N neurons. Biochimie 2010; 92: 245-253.
4. Tai LM, Holloway KA, Male DK, Loughlin AJ, Romero IA. Amyloid-beta-induced occludin down-regulation and increased permeability in human brain endothelial cells is mediated by MAPK activation. J Cell Mol Med 2010; 14: 1101-1112.
5. Zheng YH, Chen CH. Protective effects of allicin on acute cerebral ischemia-reperfusion injury in rats. Chinese Pharmacological Bulletin 2004; 20: 821-824.
6. Zhang JL, Sun RJ, Shi ZX. [Effect of garlicin on adhesion molecules expression and deformability of peripheral neutrophils in patients with acute cerebral infarction] Zhongguo Zhong Xi Yi Jie He Za Zhi 2002; 22: 423-425. Chinese.
7. Li CY, Liu XY, Bu H, Li Z, Li B, Sun MM, et al. Prevention of glutamate excitotoxicity in motor neurons by 5,6- dihydrocyclopenta-1,2-dithiole-3-thione: implication to the development of neuroprotective drugs. Cell Mol Life Sci 2007; 64: 1861-1869.
8. Wang JZ, Gao D, Gao C, Yao GE, Zhou HJ, Zhang LL, et al. Changes of interleukin-1B and TNF-A in the hippocampus and the interventional effect of garlicin on vascular dementia in rats. Acta Academiae Medicinae Militaris Tertiae 2004; 26: 1515-1517.
9. Choi Y, Kim HS, Shin KY, Kim EM, Kim M, Kim HS, et al. Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer's disease models. Neuropsychopharmacology 2007; 32: 2393-2404.
10. Giovannini MG, Scali C, Prosperi C, Bellucci A, Vannucchi MG, Rosi S, et al. Beta-amyloid-induced inflammation and cholinergic hypofunction in the rat brain in vivo: involvement of the p38MAPK pathway. Neurobiol Dis 2002; 11: 257-274.
11. Tamagno E, Robino G, Obbili A, Bardini P, Aragno M, Parola M, et al. H2O2 and 4-hydroxynonenal mediate amyloid betainduced neuronal apoptosis by activating JNKs and p38MAPK. Exp Neurol 2003; 180: 144-155.
12. Bard F, Barbour R, Cannon C, Carretto R, Fox M, Games D, et al. Epitope and isotype specificities of antibodies to beta - amyloid peptide for protection against Alzheimer's disease-like neuropathology. Proc Natl Acad Sci U S A 2003; 100: 2023-2028.
13. Zhao L, He M, Jin WB, Zhao HS, Yao WF, Wei MJ. Vitamin E administration improves learning and memory deficits in modeling Alzheimer's disease. Chin J Clin Pharmacol Ther 2009; 14: 25-31.
14. Masliah E, Hansen L, Adame A, Crews L, Bard F, Lee C, et al. Abeta vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease. Neurology 2005; 64: 129-131.
15. Talebi M, Farhodi M, Nikanfar M, Majidi J, Fakhari A. Study on serum homocysteine level in Alzheimer's disease and its relationship with the stages of this disease. Neurosciences 2008; 13: 359-362.